<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">161</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2019-27-si1-630-636</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>Moscow Screening: Lung Cancer Screening With Low-Dose Computed Tomography</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Morozov</surname><given-names>S. P.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kuzmina</surname><given-names>E. S.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vetsheva</surname><given-names>N. N.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gombolevskiy</surname><given-names>V. A.</given-names></name><bio></bio><email>gombolevskiy@npcmr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lantukh</surname><given-names>Z. A.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Polishuk</surname><given-names>N. S.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Laipan</surname><given-names>A. Sh.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ermolaev</surname><given-names>S. O.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Panina</surname><given-names>E. V.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blokhin</surname><given-names>I. A.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies</aff><pub-date date-type="epub" iso-8601-date="2019-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2019</year></pub-date><volume>27</volume><fpage>630</fpage><lpage>636</lpage><history><pub-date date-type="received" iso-8601-date="2021-04-06"><day>06</day><month>04</month><year>2021</year></pub-date></history><permissions><copyright-statement>Copyright © 2019,</copyright-statement><copyright-year>2019</copyright-year></permissions><abstract>For the first time in Moscow and Russia, a program of selective lung cancer screening has been implemented with a comprehensive approach, including organizational, management, medical, technical and educational aspects and quality control. Unique ultra-low-dose protocols (ultra-LDCT) have been developed to implement the screening program. These protocols allow performing high-quality chest computed tomography for lung nodule detection with an effective dose of less than 1 mSv. The possibility of using neural networks (“artificial intelligence”) for quality control of screening results has been proven for the first time.</abstract><kwd-group xml:lang="en"><kwd>lung cancer</kwd><kwd>low-dose computed tomography</kwd><kwd>detectability</kwd><kwd>patient routing</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>скрининг рака</kwd><kwd>рак легкого</kwd><kwd>низкодозовая компьютерная томография</kwd><kwd>выявляемость</kwd><kwd>маршрутизация</kwd><kwd>сancer screening</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>The top 10 causes of death. World Health Organization. 24 May 2018. Режим доступа: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer. J. Clin. 2018 Nov; 68(6):394-424. doi: 10.3322/caac.21492</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Каприн А. Д., Старинский В. В., Петрова Г. В. Состояние онкологической помощи населению России в 2016 году. М.; 2017. С. 236.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Каприн А. Д., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2016 г. (заболеваемость и смертность). М.; 2018. С. 250.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Gohagan J. K., Prorok P. C., Hayes R. B., Kramer B. S. Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control. Clin. Trials. 2000;21:251-72.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Nelson Lung Cancer Screening Study Confirms NLST Results. ACR. 25 September 2018. Режим доступа: https://www.acr.org/Media-Center/ACR-News-Releases/2018/Nelson-Lung-Cancer-Screening-Study-Confirms-NLST-Results?fbclid=IwAR15uesIASg_ 8I8RH3Tak2LRuy3CUBXmAl1MbjBlSn2xuYQfpKrrsTuEzpU</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Рекомендации по ранней диагностике рака легкого для врачей первичного звена. Вестник рентгенологии и радиологии. 2016;97(2):69-78.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Lung-RADS™ Version 1.0 Assessment Categories Release. 28 April 2014. Режим доступа: https://www.acr.org/-/media/ACR/Files/RADS/Lung-RADS/LungRADS_AssessmentCategories.pdf?la= en</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Rembold C. M. Number needed to screen: development of a statistic for disease screening. B. M. J. 1998 Aug 1;317(7154):307-12.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Morozov S., Guseva E., Ledikhova N., Vladzymyrskyy A., Safronov D. Telemedicine-based system for quality management and peer review in radiology. Insights Imaging. 2018 Jun;9(3):337-41. doi: 10.1007/s13244-018-0629-y</mixed-citation></ref></ref-list></back></article>
